Get the full picture
Sign in to uncover key details.
Avelas Biosciences
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
11099 N Torrey Pines Rd Ste 290, La Joll...Phone Number
(858) 750-4700Website
www.avelasbio.comRevenue
$20.7 MillionIndustry
About Avelas Biosciences
Avelas Biosciences is a biotechnology company focused on developing pegloprastide (AVB-620), a novel drug-device combination product for use during cancer surgery. Pegloprastide is designed to improve surgery by detecting cancer in real time and has the potential to become part of standard-of-care treatment for a variety of cancer surgeries. Avelas was founded on technology from Roger Y. Tsien, Ph.D., co-winner of the Nobel Prize in Chemistry 2008.Explore more
Avelas Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Avelas Biosciences
Compare insights from companies similar to Avelas Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Avelas Biosciences Tech Stack
A closer look at the technologies used by Avelas Biosciences
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Avelas Biosciences
Sign Up For FreeTo access detailed company insights
Avelas Biosciences is a biotechnology company focused on developing pegloprastide (AVB-620), a novel drug-device combination product for use during cancer surgery. Pegloprastide is designed to improve surgery by detecting cancer in real time and has the potential to become part of standard-of-care treatment for a variety of cancer surgeries. Avelas... Read More
